Movement Alert|Tempus AI Rises 5.15% in Regular Trading, Market Positions for Earnings Recovery Ahead of Q2 Report

Market Focus03:44

On July 30, Tempus AI rose 5.15% in regular trading, trading at $43.77 per share, with turnover of $219 million. The rally came as the company was scheduled to release its second-quarter earnings after the close, prompting concentrated pre-earnings positioning.

Market consensus expects Q2 revenue of approximately $380 million, representing a 27.92% year-over-year increase, with adjusted earnings per share of -$0.14, reflecting a 42.40% year-over-year improvement. In the prior quarter, the company reported revenue of $348 million (up 36.12% YoY) with a gross margin of 63.78% and adjusted EPS of -$0.13.

Additionally, Tempus AI recently announced a $1.5 billion enterprise value acquisition of cancer detection company Personalis, integrating molecular residual disease testing into its AI-driven precision oncology platform. Needham assessed the acquisition valuation as reasonable, citing strong growth prospects in the NeXT Personal platform and large MRD market opportunity. The stock had previously pulled back following the deal announcement, and the current rally reflects market expectations of earnings-driven recovery.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment